Type II alveolar cell MHCII improves respiratory viral disease outcomes while exhibiting limited antigen presentation

por Sushila A. Toulmin, Chaitali Bhadiadra, Andrew J. Paris, Jeffrey H. Lin, Jeremy Katzen, Maria C. Basil, Edward E. Morrisey, G. Scott Worthen, Laurence C. Eisenlohr
Publicado 2021